☰

Ryan A. Boyd, Ph.D.

Affiliations: 
2012 English University of California, Santa Barbara, Santa Barbara, CA, United States 
Area:
American Literature, Environmental Studies, American Studies, Modern Literature
Google:
"Ryan Boyd"

Parents

Sign in to add mentor
Yunte Huang grad student 2012 UC Santa Barbara
 (Medium Nature: American Poetry in the Suburban Age.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Frost C, Chang M, Yu Z, et al. (2016) Response to Letter to the Editor From Drs. Stöllberger and Finsterer: Original Publication: "Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Apixaban". Journal of Clinical Pharmacology. 56: 648-9
Vakkalagadda B, Frost C, Byon W, et al. (2016) Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa. American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Chang M, Yu Z, Shenker A, et al. (2015) Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban. Journal of Clinical Pharmacology
Wang X, Tirucherai G, Marbury TC, et al. (2015) Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis. Journal of Clinical Pharmacology
Frost C, Boyd RA. (2015) The contribution of apixaban renal clearance to total clearance. Journal of Thrombosis and Thrombolysis
Frost CE, Byon W, Song Y, et al. (2015) Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. British Journal of Clinical Pharmacology. 79: 838-46
Frost C, Song Y, Barrett YC, et al. (2014) A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban. Clinical Pharmacology : Advances and Applications. 6: 179-87
Frost C, Shenker A, Gandhi MD, et al. (2014) Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban. British Journal of Clinical Pharmacology. 78: 877-85
Wang X, Mondal S, Wang J, et al. (2014) Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects American Journal of Cardiovascular Drugs. 14: 147-154
Cohen AT, Boyd RA, Mandema JW, et al. (2013) An adaptive-design dose-ranging study of PD 0348292, an oral factor Xa inhibitor, for thromboprophylaxis after total knee replacement surgery. Journal of Thrombosis and Haemostasis : Jth. 11: 1503-10
See more...